Comparative analysis of paracrine factor expression in human adult mesenchymal stem cells derived from bone marrow, adipose, and dermal tissue

Stem Cells and Development

Volumn 21, Issue 12, 2012, Pages 2189-2203

  Hsiao, Sarah Tzu Feng ^a,b   Asgari, Azar ^a,b   Lokmic, Zerina ^a,b   Sinclair, Rodney ^b   Dusting, Gregory James ^a,b,c   Lim, Shiang Yong ^a,b   Dilley, Rodney James ^a,b,d  

^a O'Brien Institute   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c CENTRE FOR EYE RESEARCH AUSTRALIA   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIN; FIBROBLAST GROWTH FACTOR 2; INTERLEUKIN 8; LEPTIN; MESSENGER RNA; NERVE GROWTH FACTOR; SOMATOMEDIN C; VASCULOTROPIN A; VASCULOTROPIN D;

ADIPOSE TISSUE; ANGIOGENESIS; ARTICLE; BONE MARROW; COMPARATIVE STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; MESENCHYMAL STEM CELL; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN;

ADULT STEM CELLS; BONE MARROW CELLS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; ENDOTHELIAL CELLS; GENE EXPRESSION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MESENCHYMAL STROMAL CELLS; MICROVESSELS; NEOVASCULARIZATION, PHYSIOLOGIC; PARACRINE COMMUNICATION; PRIMARY CELL CULTURE; SKIN; SUBCUTANEOUS FAT;

EID: 84860425709     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2011.0674     Document Type: Article

References (71)

1. Johnston IA. (1982). Capillarisation, oxygen diffusion dis-tances and mitochondrial content of carp muscles following acclimation to summer and winter temperatures. Cell Tissue Res 222:325-337.
2. Zuk PA, M Zhu, P Ashjian, DA De Ugarte, JI Huang, H Mizuno, ZC Alfonso, JK Fraser, P Benhaim and MH He-drick. (2002). Human adipose tissue is a source of multi-potent stem cells. Mol Biol Cell 13:4279-4295.
3. Haynesworth SE, J Goshima, VM Goldberg and AI Caplan (1992). Characterization of cells with osteogenic potential from human marrow. Bone 13:81-88.
4. Yoo JU, TS Barthel, K Nishimura, L Solchaga, AI Caplan, VM Goldberg and B Johnstone. (1998). The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells. J Bone Joint Surg Am 80:1745-1757.
5. Choi YS, GJ Dusting, S Stubbs, S Arunothayaraj, XL Han, P Collas, WA Morrison and RJ Dilley. (2010). Differentiation of human adipose-derived stem cells into beating cardiomyo-cytes. J Cell Mol Med 14:878-889.
6. Narita Y, A Yamawaki, H Kagami, M Ueda and Y Ueda. (2008). Effects of transforming growth factor-beta 1 and ascorbic acid on differentiation of human bone-marrow-derived mesenchymal stem cells into smooth muscle cell lineage. Cell Tissue Res 333:449-459.
7. Studeny M, FC Marini, JL Dembinski, C Zompetta, M Cabreira-Hansen, BN Bekele, RE Champlin and M Andreeff. (2004). Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst 96:1593-1603.
8. Wang Q, B Sun, D Wang, Y Ji, Q Kong, G Wang, J Wang, W Zhao, L Jin and H Li. (2008). Murine bone marrow mesen-chymal stem cells cause mature dendritic cells to promote T-cell tolerance. Scand J Immunol 68:607-615.
9. Kofidis T, JL de Bruin, T Yamane, M Tanaka, DR Lebl, RJ Swijnenburg, IL Weissman and RC Robbins. (2005). Stimu-lation of paracrine pathways with growth factors enhances embryonic stem cell engraftment and host-specific differen-tiation in the heart after ischemic myocardial injury. Circulation 111:2486-2493.
10. Li L, S Zhang, Y Zhang, B Yu, Y Xu and Z Guan. (2009). Paracrine action mediate the antifibrotic effect of trans-planted mesenchymal stem cells in a rat model of global heart failure. Mol Biol Rep 36:725-731.
11. Shabbir A, D Zisa, H Lin, M Mastri, G Roloff, G Suzuki and T Lee. (2010). Activation of host tissue trophic factors through JAK-STAT3 signaling: a mechanism of mesenchy-mal stem cell-mediated cardiac repair. Am J Physiol Heart Circ Physiol 299:H1428-H1438.
12. Kinnaird T, E Stabile, MS Burnett, CW Lee, S Barr, S Fuchs and SE Epstein. (2004). Marrow-derived stromal cells ex-press genes encoding a broad spectrum of arteriogenic cy-tokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 94:678-685.
13. Hoffmann J, AJ Glassford, TC Doyle, RC Robbins, S Schrepfer and MP Pelletier. (2010). Angiogenic effects de-spite limited cell survival of bone marrow-derived mesen-chymal stem cells under ischemia. Thorac Cardiovasc Surg 58:136-142.
14. Nguyen BK, S Maltais, LP Perrault, JF Tanguay, JC Tardif, LM Stevens, M Borie, F Harel, S Mansour and N Noiseux. (2010). Improved function and myocardial repair of in-farcted heart by intracoronary injection of mesenchymal stem cell-derived growth factors. J Cardiovasc Transl Res 3:547-558.
15. Caplan AI. (1991). Mesenchymal stem cells. J Orthop Res 9:641-650.
16. Pittenger MF, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
17. Zhang X, M Hirai, S Cantero, R Ciubotariu, L Dobrila, A Hirsh, K Igura, H Satoh, I Yokomi, et al. (2011). Isolation and characterization of mesenchymal stem cells from human umbilical cord blood: reevaluation of critical factors for successful isolation and high ability to proliferate and dif-ferentiate to chondrocytes as compared to mesenchymal stem cells from bone marrow and adipose tissue. J Cell Biochem 112:1206-1218.
18. Jahoda CA and RF Oliver. (1984). Vibrissa dermal papilla cell aggregative behaviour in vivo and in vitro. J Embryol Exp Morphol 79:211-224.
19. Wagner W, F Wein, A Seckinger, M Frankhauser, U Wirkner, U Krause, J Blake, C Schwager, V Eckstein, W Ansorge and AD Ho. (2005). Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol 33:1402-1416.
20. Niemeyer P, M Kornacker, A Mehlhorn, A Seckinger, J Vohrer, H Schmal, P Kasten, V Eckstein, NP Sudkamp and U Krause. (2007). Comparison of immunological properties of bone marrow stromal cells and adipose tissue-derived stem cells before and after osteogenic differentiation in vitro. Tissue Eng 13:111-121.
21. Puissant B, C Barreau, P Bourin, C Clavel, J Corre, C Bous-quet, C Taureau, B Cousin, M Abbal, et al. (2005). Im-munomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchy-mal stem cells. Br J Haematol 129:118-129.
22. Liu TM, M Martina, DW Hutmacher, JH Hui, EH Lee and B Lim. (2007). Identification of common pathways mediating differentiation of bone marrow-and adipose tissue-derived human mesenchymal stem cells into three mesenchymal lineages. Stem Cells 25:750-760.
23. Niemeyer P, K Fechner, S Milz, W Richter, NP Suedkamp, AT Mehlhorn, S Pearce and P Kasten. (2010). Comparison of mesenchymal stem cells from bone marrow and adipose tissue for bone regeneration in a critical size defect of the sheep tibia and the influence of platelet-rich plasma. Bio-materials 31:3572-3579.
24. Ikegame Y, K Yamashita, SI Hayashi, H Mizuno, M Tawada, F You, K Yamada, Y Tanaka, Y Egashira, et al. (2011). Com-parison of mesenchymal stem cells from adipose tissue and bone marrow for ischemic stroke therapy. Cytotherapy 13:13.
25. Kim Y, H Kim, H Cho, Y Bae, K Suh and J Jung. (2007). Direct comparison of human mesenchymal stem cells de-rived from adipose tissues and bone marrow in mediating neovascularization in response to vascular ischemia. Cell Physiol Biochem 20:867-876.
26. Jahoda C and RF Oliver. (1981). The growth of vibrissa dermal papilla cells in vitro. Br J Dermatol 105:623-627
27. Magerl M, S Kauser, R Paus and DJ Tobin. (2002). Simple and rapid method to isolate and culture follicular papillae from human scalp hair follicles. Exp Dermatol 11:381-385.
28. Dominici M, K Le Blanc, I Mueller, I Slaper-Cortenbach, F Marini, D Krause, R Deans, A Keating, D Prockop and E Horwitz. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317.
29. Cheung CY. (1997). Vascular endothelial growth factor: possible role in fetal development and placental function. J Soc Gynecol Investig 4:169-177.
30. Ishizawa K, H Kubo, M Yamada, S Kobayashi, T Suzuki, S Mizuno, T Nakamura and H Sasaki. (2004). Hepatocyte growth factor induces angiogenesis in injured lungs through mobilizing endothelial progenitor cells. Biochem Biophys Res Commun 324:276-280.
31. Deuse T, C Peter, PW Fedak, T Doyle, H Reichenspurner, WH Zimmermann, T Eschenhagen, W Stein, JC Wu, RC Robbins and S Schrepfer. (2009). Hepatocyte growth factor or vascular endothelial growth factor gene transfer maxi-mizes mesenchymal stem cell-based myocardial salvage af-ter acute myocardial infarction. Circulation 120:S247-S254.
32. Peng L, Z Jia, X Yin, X Zhang, Y Liu, P Chen, K Ma and C Zhou. (2008). Comparative analysis of mesenchymal stem cells from bone marrow, cartilage, and adipose tissue. Stem Cells Dev 17:761-773.
33. Maumus M, Peyrafitte J-A, D'Angelo R, Fournier-Wirth C, Bouloumie A, Casteilla L, Sengene C and Bourin P. (2011). Native human adipose stromal cells: localization, morphol-ogy and phenotype. Int J Obesity 35:1141-1153.
34. Giordano FJ, HP Gerber, SP Williams, N VanBruggen, S Bunting, P Ruiz-Lozano, Y Gu, AK Nath, Y Huang, et al. (2001). A cardiac myocyte vascular endothelial growth fac-tor paracrine pathway is required to maintain cardiac function. Proc Natl Acad Sci USA 98:5780-5785.
35. Liu Y, Z Song, Y Zhao, H Qin, J Cai, H Zhang, T Yu, S Jiang, G Wang, M Ding and H Deng. (2006). A novel chemical-defined medium with bFGF and N2B27 supplements sup-ports undifferentiated growth in human embryonic stem cells. Biochem Biophys Res Commun 346:131-139.
36. Song EJ and YS Yoo. (2011). Nerve growth factor-induced neurite outgrowth is potentiated by stabilization of TrkA receptors. BMB Rep 44:182-186.
37. Freeman RS, RL Burch, RJ Crowder, DJ Lomb, MC Schoell, JA Straub and L Xie. (2004). NGF deprivation-induced gene expression: after ten years, where do we stand? Prog Brain Res 146:111-126.
38. Lee RJ, ML Springer, WE Blanco-Bose, R Shaw, PC Ursell and HM Blau. (2000). VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation 102:898-901.
39. Thurston G. (2003). Role of angiopoietins and Tie receptor tyrosine kinases in angiogenesis and lymphangiogenesis. Cell Tissue Res 314:61-68.
40. Preissner KT, J Grulich-Henn, HJ Ehrlich, P Declerck, C Justus, D Collen, H Pannekoek and G Muller-Berghaus. (1990). Structural requirements for the extracellular interac-tion of plasminogen activator inhibitor 1 with endothelial cell matrix-associated vitronectin. J Biol Chem 265:18490-18498.
41. Xu J, J Qu, L Cao, Y Sai, C Chen, L He and L Yu. (2008). Mesenchymal stem cell-based angiopoietin-1 gene therapy for acute lung injury induced by lipopolysaccharide in mice. J Pathol 214:472-481.
42. Chen SL, CC Zhu, YQ Liu, LJ Tang, L Yi, BJ Yu and DJ Wang. (2009). Mesenchymal stem cells genetically modified with the angiopoietin-1 gene enhanced arteriogenesis in a porcine model of chronic myocardial ischaemia. J Int Med Res 37:68-78.
43. Conrad C, H Niess, R Huss, S Huber, I von Luettichau, PJ Nelson, HC Ott, KW Jauch and CJ Bruns. (2009). Multipotent mesenchymal stem cells acquire a lymphendothelial phe-notype and enhance lymphatic regeneration in vivo. Circulation 119:281-289.
44. Hwang JH, IG Kim, JY Lee, S Piao, DS Lee, TS Lee and JC Ra. (2011). Therapeutic lymphangiogenesis using stem cell and VEGF-C hydrogel. Biomaterials 32:4415-4423.
45. Veikkola T, L Jussila, T Makinen, T Karpanen, M Jeltsch, TV Petrova, H Kubo, G Thurston, DM McDonald, et al. (2001). Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO J 20:1223-1231.
46. Baldwin ME, MM Halford, S Roufail, RA Williams, ML Hibbs, D Grail, H Kubo, SA Stacker and MG Achen. (2005). Vascular endothelial growth factor D is dispensable for de-velopment of the lymphatic system. Mol Cell Biol 25:2441-2449.
47. Rissanen TT, JE Markkanen, M Gruchala, T Heikura, A Puranen, MI Kettunen, I Kholova, RA Kauppinen, MG Achen, et al. (2003). VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses. Circ Res 92:1098-1106.
48. Ohnishi S, T Yasuda, S Kitamura and N Nagaya. (2007). Effect of hypoxia on gene expression of bone marrow-derived mesenchymal stem cells and mononuclear cells. Stem Cells 25:1166-1177.
49. Ferrara N, K Carver-Moore, H Chen, M Dowd, L Lu, KS O'Shea, L Powell-Braxton, KJ Hillan and MW Moore. (1996). Heterozygous embryonic lethality induced by targeted in-activation of the VEGF gene. Nature 380:439-442.
50. Achen MG, M Jeltsch, E Kukk, T Makinen, A Vitali, AF Wilks, K Alitalo and SA Stacker. (1998). Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine ki-nases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci USA 95:548-553.
51. Jia H, A Bagherzadeh, R Bicknell, MR Duchen, D Liu and I Zachary. (2004). Vascular endothelial growth factor (VEGF)-D and VEGF-A differentially regulate KDR-mediated sig-naling and biological function in vascular endothelial cells. J Biol Chem 279:36148-36157.
52. Vicennati V, A Vottero, C Friedman and DA Papanicolaou. (2002). Hormonal regulation of interleukin-6 production in human adipocytes. Int J Obes Relat Metab Disord 26:905-911.
53. Qian H, GJ Hausman, MM Compton, MJ Azain, DL Hartzell and CA Baile. (1998). Leptin regulation of peroxisome pro-liferator-activated receptor-gamma, tumor necrosis factor, and uncoupling protein-2 expression in adipose tissues. Biochem Biophys Res Commun 246:660-667.
54. Mitchell SE, WD Rees, LJ Hardie, N Hoggard, M Tadayyon, JR Arch and P Trayhurn. (1997). ob gene expression and secretion of leptin following differentiation of rat pre-adipocytes to adipocytes in primary culture. Biochem Bio-phys Res Commun 230:360-364.
55. Iguchi M, S Aiba, Y Yoshino and H Tagami. (2001). Human follicular papilla cells carry out nonadipose tissue produc-tion of leptin. J Invest Dermatol 117:1349-1356.
56. Hoggard N, L Hunter, JS Duncan, LM Williams, P Trayhurn and JG Mercer. (1997). Leptin and leptin receptor mRNA and protein expression in the murine fetus and placenta. Proc Natl Acad Sci USA 94:11073-11078.
57. Chen SC, JJ Cunningham and RJ Smeyne. (2000). Expression of OB receptor splice variants during prenatal development of the mouse. J Recept Signal Transduct Res 20:87-103.
58. Sumikawa Y, T Nakajima, S Inui and S Itami. (2008). Leptin is a paracrine regulator of hair cycle. J Invest Dermatol 128:S146-S876.
59. Poeggeler B, C Schulz, MA Pappolla, E Bodo, S Tiede, H Lehnert and R Paus. (2010). Leptin and the skin: a new frontier. Exp Dermatol 19:12-18.
60. Larcher F, M Del Rio, F Serrano, JC Segovia, A Ramirez, A Meana, A Page, JL Abad, et al. (2001). A cutaneous gene therapy approach to human leptin deficiencies: correction of the murine ob/ob phenotype using leptin-targeted kerati-nocyte grafts. FASEB J 15:1529-1538.
61. Murad A, AK Nath, ST Cha, E Demir, J Flores-Riveros and MR Sierra-Honigmann. (2003). Leptin is an autocrine/paracrine regulator of wound healing. FASEB J 17:1895-1897.
62. Schindler R, J Mancilla, S Endres, R Ghorbani, SC Clark and CA Dinarello. (1990). Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 sup-presses IL-1 and TNF. Blood 75:40-47.
63. Mukaida N. (2000). Interleukin-8: an expanding universe beyond neutrophil chemotaxis and activation. Int J Hematol 72:391-398.
64. Zhu Y, T Liu, H Ye, K Song, X Ma and Z Cui. (2010). En-hancement of adipose-derived stem cell differentiation in scaffolds with IGF-I gene impregnation under dynamic mi-croenvironment. Stem Cells Dev 19:1547-1556.
65. Wei HJ, CH Chen, WY Lee, I Chiu, SM Hwang, WW Lin, CC Huang, YC Yeh, Y Chang and HW Sung. (2008). Bioengi-neered cardiac patch constructed from multilayered mes-enchymal stem cells for myocardial repair. Biomaterials 29:3547-3556.
66. Vidal MA, GE Kilroy, MJ Lopez, JR Johnson, RM Moore and JM Gimble. (2007). Characterization of equine adipose tis-sue-derived stromal cells: adipogenic and osteogenic ca-pacity and comparison with bone marrow-derived mesenchymal stromal cells. Vet Surg 36:613-622.
67. Moretti P, T Hatlapatka, D Marten, A Lavrentieva, I Majore, R Hass and C Kasper. (2010). Mesenchymal stromal cells derived from human umbilical cord tissues: primitive cells with potential for clinical and tissue engineering applica-tions. Adv Biochem Eng Biotechnol 123:29-54.
68. Choi YS, K Matsuda, GJ Dusting, WA Morrison and RJ Dilley. (2010). Engineering cardiac tissue in vivo from hu-man adipose-derived stem cells. Biomaterials 31:2236-2242.
69. Puxeddu I, D Ribatti, E Crivellato and F Levi-Schaffer. (2005). Mast cells and eosinophils: a novel link between in-flammation and angiogenesis in allergic diseases. J Allergy Clin Immunol 116:531-536.
70. Koch AE, PJ Polverini, SL Kunkel, LA Harlow, LA DiPietro, VM Elner, SG Elner and RM Strieter. (1992). Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258:1798-1801.
71. Kocher AA, MD Schuster, N Bonaros, K Lietz, G Xiang, TP Martens, PA Kurlansky, H Sondermeijer, P Witkowski, et al. (2006). Myocardial homing and neovascularization by human bone marrow angioblasts is regulated by IL-8/Gro CXC chemokines. J Mol Cell Cardiol 40:455-464.